U. Halm et al., Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus, HEP-GASTRO, 47(34), 2000, pp. 962-966
Background/Aims: The regulation of apoptosis as a distinctive form of cell
death and proliferation in the process of carcinogenesis in Barrett's esoph
agus is poorly understood. To investigate regulation of apoptosis, prolifer
ation and the participation of the tumor suppressor gene p53, we examined t
hese parameters in Barrett's metaplasia, dysplasia, and adenocarcinoma.
Methodology: Apoptotic cells were identified and quantified in tissue speci
mens of 45 patients with different stages of Barrett's esophagus and normal
fundus epithelium, respectively, using the in situ end-labeling and electr
on microscopy method in combination with morphological criteria. The tumor
suppressor gene p53 was examined by direct sequencing of exon 4-8 as well a
s immunohistochemically. The proliferative activity was assessed by Ki67 im
munostaining.
Results: Apoptotic cell death, identified by the in situ end-labeling and u
ltrastructural technique was significantly increased in Barrett's epitheliu
m with intestinal metaplasia than in specimens with normal fundic epitheliu
m and Barrett's carcinomas (P<0.01). The proliferative activity, defined as
Ki67 labeling index, was highest in adenocarcinomas (P<0.01). P53 mutation
s were found in 8/9 adeno carcinomas and 2/5 specimens with dysplasia. Apop
tosis was lower in p53 positive specimens of the metaplasia-dysplasia-carci
noma-sequence than in p53 negative specimens of Bal rett's esophagus (P<0.0
5).
Conclusions: The higher levels of both apoptosis and proliferation indicate
an increased cell turnover in Barrett's epithelium. Apoptosis seems to mai
ntain tissue homeostasis, which is regulated by p53, and gradually lost in
the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus.